Advertisement

Ads Placeholder
Loading...

ARK Genomic Revolution ETF

ARKG•AMEX
Financial Services
Asset Management
$27.36
$0.27(1.00%)
U.S. Market opens in 54h 58m

ARK Genomic Revolution ETF (ARKG) Stock Overview

Explore ARK Genomic Revolution ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$25.83
3 Months$27.33
1 Year Target$31.09

ARKG Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ARK Genomic Revolution ETF (ARKG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.00%
5-Day Change
4.07%
1-Month Change
-5.88%
3-Month Change
-6.24%
6-Month Change
-8.92%
Year-to-Date (YTD) Change
-6.24%
1-Year Change
38.60%
3-Year Change
-8.06%
5-Year Change
-69.86%
All-Time (Max) Change
36.12%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

IPO DateOct 31, 2014
CountryUS
Actively Trading

Frequently Asked Questions